chemotherapy

Gene Assays, New Treatments & the Silver Tsunami

DCI faculty Michaela Dinan, PhD, on the impact of the Oncotype DX test on HR+ breast cancer patients over 65, treatment disparities, & the latest therapies.

October 8, 2020

DCI Research

Collage of Kathy Jennings at the Ovarian Cancer Walk and in various stages of treatment

UnTEAL There’s A Cure, Have Faith in the Fight

Diagnosed with stage 4 ovarian cancer three years ago, Kathy Jennings was thrown a lifeline when she came to Duke Cancer Center.

August 13, 2020

DCI Research Patient Stories

Drug Makes Tumors More Susceptible To Chemo

Researchers at MIT and Duke have discovered that a compound that knocks out a DNA repair pathway enhances cisplatin treatment and helps prevent drug-resistance.

June 7, 2019

DCI Research

Aptamers May Form New, Safer Chemotherapy Delivery Systems

Using chemotherapy along with aptamers—lab-made molecules that function like antibodies—Duke Health researchers showed that they can zero in on and ki...

April 18, 2018

Announcements DCI Research

How Common Chemotherapy Drugs Work

A study by scientists at Duke Health is providing insight into how certain commonly-used chemotherapy drugs work, potentially opening new ways ...

June 15, 2016

Announcements DCI Research

New Antibody May Re-Activate Immune System in Cancer Therapy

Adding an investigational antibody to the chemotherapy rituximab appears to restore its cancer-killing properties in certain leukemia patients with a ...

June 27, 2017

Announcements DCI Research

Duke Nurse Turned Cancer Survivor

Bethany Clements, 54, has been an oncology nurse at Duke Cancer Institute for the past 25 years. Clements dedicated her career to helping others battl...

March 7, 2018

Patient Stories

Shared Resource: Investigational Chemotherapy Service Lab

The Investigational Chemotherapy Service is one of two labs making up the Pharmaceutical Shared Resource. Putting a new cancer medication through the ...

July 7, 2015

DCI Research Shared Resources